XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Price weighting can skew an index toward higher-priced stocks. This explanation covers implications for interpretation and strategy.
26,155 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Leveraged ETFs can move markets fast, but that speed cuts both ways. This guide explains how they work, the risks of ...
The S&P 500 exhibits a pronounced tech tilt as AI leaders drive gains. But a rising concentration risk could redefine...
A triple-leveraged ETF focused on semiconductors can swing wildly. This piece breaks down why the direxion daily semi...
The sudden question, spacex stock drop today?, often shows up after big index moves. This guide breaks down why those...
Marvell Technology recently joined a prestigious club by entering the S&P 500, set to start trading in June. This gui...
Smart investing starts with a clear plan. This guide breaks down proven investment strategies, from passive index fun...
In 2026, three popular tech ETFs tell three different stories about how to own technology: FTEC offers broad exposure...
Healthcare sector ETFs offer defense and income, but not all are created equal. This article dives into how state str...
As AI stocks drive gains, traders debate whether equal-weighted ETFs like RSP can outpace SPY’s cap-weighted edge. He...
Healthcare investing comes in two main flavors: a market-weighted healthcare active manager approach and a more passi...
SpaceX joins the Nasdaq-100, setting up a mechanical buy flow for index funds. Analysts estimate about $4.3 billion i...